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Abstract  17 
The protection provided by the human skin is mostly attributed to the stratum corneum. However, 18 
this barrier also limits the range of molecules that can be delivered into and across the skin. One of 19 
the methods to overcome this physiological barrier and improve the delivery of molecules into and 20 
across the skin is via the use of microneedles. This work evaluates the mechanical insertion of two 21 
different commercially available microneedle systems, Dermapen® and DermastampTM. The influence 22 
of biaxial skin strain on the penetration of the two microneedle systems was evaluated ex vivo using 23 
a biaxial stretch rig. From the skin insertion study, it was apparent that for all levels of biaxial strain 24 
investigated, the Dermapen® required less force than the DermastampTM to puncture the skin. In 25 
addition, it was observed that the oscillating microneedle system, the Dermapen®, resulted in deeper 26 
skin insertion ex vivo in comparison to the Dermastamp™. The use of this new biaxial stretch rig and 27 
the ex vivo skin insertion depth study highlights that the oscillating Dermapen® required less force to 28 
perforate the skin at varying biaxial strain whilst resulting in deeper skin penetration ex vivo in 29 
comparison to the DermastampTM. Although the Dermapen® punctured the skin deeper than the 30 
DermastampTM, such difference in penetration did not influence the permeation profile of the model 31 








1. Introduction 38 
The human skin is the largest organ in the human body and is comprised of three layers; the epidermis, 39 
dermis and hypodermis. The epidermis is a multilayer compartment of the skin that comprises of the 40 
stratum corneum (SC), stratum granulosum, stratum spinosum and stratum basale [1]. The outermost 41 
layer of the epidermis, the stratum corneum, is avascular and has evolved to provide protection 42 
against physical and chemical attack. The protection provided by the stratum corneum has also 43 
resulted in a barrier to the delivery of compounds across the skin either for therapeutic or cosmetic 44 
purposes [2].  45 
Microneedles are one of the strategies explored to improve the delivery of compounds across the 46 
skin. These are minimally-invasive needles with lengths that ranging between 250-1000 µm capable 47 
of perforating the stratum corneum in order to promote the delivery of compound across the skin [3]. 48 
Due to their size, microneedles offer painless skin insertion as they are unlikely to stimulate the dermal 49 
pain receptors upon application [4].  Some of the microneedle products available on the market, 50 
licensed for cosmetic use, include the DermastampTM and Dermapen®.  51 
The DermastampTM consists of a stamp with an array of microneedles arranged at the base of the 52 
device. The microneedles are inserted into the skin in one vertical motion, creating micron sized 53 
channels in the skin. The Dermapen® is a motor driven microneedling device that inserts its needles 54 
into the skin in a continuous oscillating motion at one of five programmed frequency levels. The use 55 
of a motor helps circumvent the issue of varying insertion force between users. It also features an 56 
adjustable dial to control the needle’s depth of penetration during use. However, little research exists 57 
evaluating the effectiveness of such a motor driven device or the associated advantages or 58 
disadvantages in its use in comparison to the Dermastamp™ and its single stamping motion.  59 
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In order to effectively generate microneedle channels, the skins topology must also be considered. 60 
The human skin features a roughened surface due to the variation in structure of the keratinocytes on 61 
the stratum corneum [5,6]. This surface is undulating in nature, being up to 150 microns from peak to 62 
trough for those aged over 60 [6], thus clearly demonstrating the need to smooth the skin as far as 63 
possible to maximise depth of penetration by the needles. To achieve smoothing, the skin must be 64 
stretched. It is understood that when skin is uniaxially stretched, the skin acts in a compressive fashion 65 
in the perpendicular direction to maintain the area of the surface, causing micro-furrows to develop 66 
[7].This highlights the need for biaxial stretching to mitigate against this and ensure microneedle 67 
insertion into the skin. Biaxial skin stretching has been performed in several studies [8–10] with a non-68 
linear stiffening of skin being found as a function of strain. This relationship has been supported by a 69 
simulation study by Flynn and Rubin[11] however little other data appears to exist regarding how 70 
increase in strain affects the penetration of microneedle into the skin.  71 
In this work, we compare the insertion force profiles of two commercially available microneedle 72 
systems; DermastampTM and Dermapen®.  This study evaluates the influence of biaxial skin strain on 73 
the insertion force of two different microneedling systems into the skin. Besides that, the influence of 74 
microneedle oscillation during microneedle application was evaluated using an in vitro and an ex vivo 75 
set up.   76 
2. Materials 77 
Dermapen® (ZJChao, China) and Dermastamp™ (Teoxy Beauty, Wuhan, China). The Dermapen® is an 78 
oscillating microneedling pen featuring a 36-needle removable array, with tip radius of 44-68 µm and 79 
conical geometry. In order to mimic how the Dermapen® would be use by a patient in a real-world 80 
setting, the plastic ring around the microneedle cartridge was not removed for all skin insertion and 81 
permeation study. The Dermastamp™ is a non-oscillating microneedle stamp featuring a 42-needle 82 
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array of 1mm length, tip radius of 21-25 µm and curved conical geometry. The geometry of the 83 
microneedles from respective devices are visualised using Leica DM4000B (Leica Microsystem, 84 
Germany). The geometry of the microneedles is shown in Figure 1. 85 
Porcine skin was used to study the insertion force profile of commercial microneedles instead of ex-86 
vivo human skin due to its limited availability and the ethical difficulties associated with its use. Various 87 
studies have highlighted that porcine skin is a suitable alternative to human [12]. Porcine flank skin 88 
samples from six-month old animals were obtained from a local abattoir, reared specifically for food. 89 
Skin were collected prior to any steam cleaning, and then prepared. The skin was washed with distilled 90 
water and dried using tissue. Full thickness skin was used to avoid altering the skins biomechanical 91 
properties, which may lead to over-penetration of microneedles into the dermal tissue [13]. After that, 92 
the skin samples were stored at -20 °C and used within six months. Gentian violet solution 1% w/v (De 93 
La Cruz products, USA) was used as a dye to highlight the microneedle channels created in porcine 94 
skin. Parafilm M® (Brand Bermis, Wertheim, Germany) of 127 µm thickness was used as a skin simulant 95 
in the in-vitro insertion study. Imiquimod was purchased from Cayman Chemicals, USA. 5% w/w 96 
imiquimod cream (AldaraTM), MEDA Company, Sweden was purchased from Manor pharmacy, UK. 97 
Sodium acetate was purchased from Sigma-Aldrich, UK. Acetonitrile (HPLC grade) and glacial acetic 98 
acid were obtained from Fisher Scientific, UK. Teepol solution (Multipurpose detergent) was ordered 99 
from Scientific Laboratory Supplies, UK. D-Squame standard sampling discs (adhesive discs) were 100 
purchased from Cuderm corporation, USA. Deionised water was obtained from an ELGA reservoir, 101 
PURELAB® Ultra, ELGA, UK. All reagents were of analytical grade, unless otherwise stated. 102 
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3. Methods 103 
3.1. Biaxial Stretch Rig Development  104 
Following two designs presented in literature [9,10], a low cost biaxial skin stretching rig was 105 
produced. The rig consists of four manual linear stages arranged as shown in Figure 2 on an 8 mm 106 
laser cut acrylic base. Further laser cut components permit clamping to be achieved using M4 Cap 107 
Head Bolts and 5mm acrylic plates. Friction between the clamping plates was improved using 40 grit 108 
emery cloth, double sided taped to the plates. The centre of the rig, over which the microneedle array 109 
is inserted, consists of an acrylic block topped with a 6mm layer of natural cork to simulate the stiffness 110 
of skeletal muscle [14] . Aluminium foil was overlaid on the cork with a thin covering of detergent. This 111 
was performed to reduce the friction experienced by the skin on the cork mat during stretching thus 112 
aiding the amount of strain that could be achieved within the skin.  In addition, a laser cut jig for 113 
locating the biaxial stretch rig on the bed of a Texture Analyser (TA), (Stable Micro Systems, Surrey, 114 
UK) was also prepared to ensure consistency of the location of insertion of the microneedle array. 115 
Zero strain was assumed for each piece of skin when initially clamped.  116 
3.2. Biaxial strain on microneedle skin insertion force  117 
In order to investigate the effect of biaxial stretching on microneedle puncture performance of the 118 
Dermapen® and DermastampTM, an insertion experiment was performed. The prepared porcine skin 119 
was inserted into the biaxial stretch rig and clamped, Figure 3 (a). The skin samples were then 120 
subjected to five levels of biaxial strain; 1.00, 1.0625, 1.125, 1.875 and 1.25 (i.e. a biaxial stretch of 121 
0mm, 2.5mm, 5mm, 7.5mm and 10mm of a 40x40 mm grid). The level of biaxial strain was measured 122 
using a 40x40 mm grid of 5 mm squares ink-stamped onto the skin samples, Figure 3(a). The skin 123 
sample was biaxially stretched and a pair of Vernier callipers used to measure the level of stretch i.e. 124 
0mm, 2.5mm, 5mm, 7.5mm and 10mm. Strain in each direction was calculated using Equation 1. 125 
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ε = Δl/l 126 
Equation 1 - Equation for strain where ε is strain, l is length, and Δl is the change in length of skin. ε 127 
strain, has no unit as the units from Δl and l cancel each other out. 128 
The skin-loaded rig was then placed under the probe of the TA, using a laser cut jig to align a quadrant 129 
with the probe’s central position. A microneedle-loaded probe, see Figure 3(b), was then attached to 130 
the TA. The following parameters were used for the TA program; 5kg Load Cell, Pre-Test Speed: 131 
0.5mm/sec, Test Speed: 0.5mm/sec, Post-Test Speed: 10mm/Sec, Trigger Force: 0.01N. The 132 
microneedles were inserted into the skin sample by the TA and the force-displacement profile 133 
recorded. Following their removal, the Gentian Violet dye was applied to the skin, Figure 3(c) to 134 
visualise the number of microneedle channels generated.  The number of microchannels generated 135 
were counted to measure the percentage of successful microneedle insertion. The DermastampTM was 136 
housed in a custom mount that consist of a turned aluminium with a roll pin used to hold the 137 
microneedle array in place. An M6 grub screw was used in the rear of the mount as an attachment to 138 
the TA. For the Dermapen®, a 3D printed (Fused Deposition Modelling) jacket was designed to house 139 
the device within an aluminium tube and stub assembly via a tapered interference fit. The assembly 140 
was then attached to the TA again by an M6 grub screw. The Dermapen®’s adjustable needle length 141 
was set to 1000 µm, the same length of the DermastampTM needles. 142 
3.3. In vitro skin simulant insertion study  143 
As an alternative method to determine the microneedle penetration depth, a polymeric film (Parafilm 144 
M®,) was used as a skin simulant. This insertion study was adopted from Larrañeta et al. 2014 [15]. In 145 
brief, eight layers of Parafilm M® were stacked onto each other on a cork layer. Both microneedle 146 
systems were applied onto the Parafilm M® stacks. Six replicates were performed, and the pores 147 
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generated were investigated under an optical microscope. The percentage of holes created per layer 148 
for respective microneedle length was calculated using following Equation 2: 149 
% hole generated: [(N microneedle channels observed)/ (N microneedles per array)] X 100 150 
Equation 2 - Equation to establish the percentage of holes produced by the microneedle devices. 151 
Where N represents ‘number of’. 152 
3.4. Ex vivo skin insertion study 153 
In order to evaluate the penetration depth of the Dermapen® and DermastampTM needles into the skin, 154 
an ex vivo penetration study using porcine skin was conducted. The porcine flank skin was defrosted 155 
at room temperature for an hour prior to the experiment. Using scissors, excess hair was carefully 156 
trimmed from the skin.  A 36-microneedle array tip was used, and the vibration speed was set to level 157 
1 (412 cycles/min) [16]. The microneedle skin pre-treatment was applied by gently stretching the skin 158 
and placing the Dermapen® vertically upon the skin for 10 seconds. A microneedle length of 1000 μm 159 
was used in this study. After treating the skin with the microneedle pen, 10 μl of 1 % Gentian Violet 160 
Dye was applied to the surface of the skin and left at room temperature for 60 minutes. Excess dye 161 
was removed and the skin was then visually inspected to identify microneedle pores. The skin samples 162 
were then cryo-sectioned (Leica CM3050 S Research Cryostat, UK) and the depth of microneedle 163 
penetration was measured under an optical microscope (Zeta Profilometer, KLA-Tencor, US). The 164 
same procedure was repeated to evaluate the depth of DermastampTM penetration into the skin.  165 
3.5. Skin permeation study 166 
In order to investigate the influence of the different microneedle system on skin permeation, an ex 167 
vivo skin permeation study using a Franz-type diffusion cell was conducted using a model compound, 168 
imiquimod. Imiquimod was selected as a model compound as the molecule displayed poor 169 
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permeation across the skin [2]. The application of microneedle system to skin is hypothesised to 170 
improve the permeation of imiquimod into the skin.  Prior to the permeation study, skin samples were 171 
defrosted for at least an hour at room temperature. The skin was trimmed into small pieces according 172 
to the surface area of the donor chamber of the Franz diffusion cell (Soham Scientific, Cambridgeshire, 173 
UK). The trimmed skin samples were equilibrated by placing them above the receptor compartment 174 
for 15 minutes prior to skin treatment. The porcine skins were subjected to the following treatment 175 
modalities: i) application of 5% w/w of imiquimod cream alone as a control ii) application of 1000 µm 176 
microneedles to the skin as a pre-treatment using Dermapen® followed by 5% w/w of imiquimod 177 
cream iii) application of 1000 µm microneedles to the skin as a pre-treatment using DermastampTM 178 
followed by 5% w/w of imiquimod cream. Next, the porcine skins were placed on top of the receptor 179 
compartment filled with 3 ml of degassed 100 mM acetate buffer pH 3.7. This buffer was selected as 180 
the receptor phase in order to maintain a sink condition throughout the permeation study. This is due 181 
to the insolubility of imiquimod at neutral or basic pH values. Various groups have reported the use of 182 
acetate buffer pH 3.7 as the receptor phase in imiquimod permeation studies [17–19]. The skin was 183 
then secured between the donor and receptor compartment of the diffusion cell using a metal clamp, 184 
with the stratum corneum side facing the donor compartment. Upon assembling the Franz diffusion 185 
cell, the permeation experiment was conducted over a period of 24 hours in a thermostatically 186 
controlled water bath set at 36.5 oC. 187 
After a 24-hour permeation experiment, the excess cream was removed and collected from the skin 188 
surface by careful application of sponges soaked with 3% v/v Teepol® solution. The sponges were 189 
pooled for imiquimod HPLC analysis as a total skin wash. Any formulation which might have spread to 190 
the donor chamber was collected by the sponges and stored for imiquimod analysis by HPLC as a 191 
donor chamber wash. Upon removing excess formulation from the skin surface, 15 sequential tape 192 
strips were collected from the skin. The amount of imiquimod from the different Franz cell elements 193 
(skin wash, donor chamber wash, pooled tape strips and remaining skin after tape stripping) were 194 
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extracted by the addition of 5, 5, 10 and 5 mL of methanol extraction mixture (Methanol 70%: Acetate 195 
Buffer pH 3.7 100 mM 30%) respectively using a previously reported method [20]. Samples were then 196 
vortexed for 1 minute and sonicated for 30 minutes before being left overnight. Subsequently, 197 
samples were vortexed again and sonicated for a further 30 minutes. 1 ml of the extracts were 198 
collected and spiked with 100 µl of 100 µg/ml propranolol as an internal standard. The samples were 199 
then filtered through 0.22 µm membrane. For the receptor fluid, 1 ml of the solution from each Franz 200 
cells were collected and spiked with 100 µl of 100 µg/ml propranolol as an internal standard before 201 
being filtered through 0.22 µm membrane. HPLC analysis was carried out using an Agilent 1100 series 202 
instrument (Agilent Technologies, Germany) equipped with degasser, quaternary pump, column 203 
thermostat, autosampler and UV detector. System control and data acquisition were performed using 204 
Chemostation software. The details of the HPLC chromatographic conditions are as follow: column 205 
C18 (150 × 4.6 mm) ACE3/ACE-HPLC Hichrom Limited, UK. The mobile phase composition for analysis 206 
of extracts from skin wash, donor chamber wash, pooled tape strips and remaining skin consists of 10 207 
mM acetate buffer: acetonitrile (79:21). Whilst, the mobile phase composition for analysis of receptor 208 
fluid consists of 10 mM acetate buffer: acetonitrile (70:30). The system operated at a flow rate of 1.0 209 
mL/minute, UV detection at λ max=226 nm, injection volume of 40 µL and column temperature of  210 
25 °C. 211 
 212 
3.6. Statistical analysis 213 
All results were reported as the mean with standard error of mean (SEM) (n≥5). Statistical calculations 214 
were performed in Prism (IBM, USA), a software package. The Student’s t-test and One-Way ANOVA 215 
followed by a Tukey HSD post-hoc test was applied to compare the results of different groups. 216 
Statistically, a significant difference was denoted by p value < 0.05. 217 
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4. Results and Discussion 218 
4.1. Influence of biaxial strain on commercial microneedle perforation.  219 
A biaxial skin stretching experiment was conducted in order to investigate the effect of skin strain on 220 
the insertion of two commercial microneedle systems. From Figure 4 it can be seen that the force 221 
needed by the Dermapen® to perforate the skin was significantly lower than the Dermastamp™ for 222 
the range of strain rates investigated.  It was also found that an increase in force was needed for the 223 
Dermastamp™ to puncture the skin as the strain increased, however this force plateaued at a biaxial 224 
strain of circa 1.1. In contrast, a linear relationship is presented for the Dermapen® suggesting that 225 
insertion force increases with a higher strain rate.  226 
The relationships shown in Figure 4, an increase in force with increases in biaxial strain, align with 227 
Lanir & Fung’s work that showed skin as a non-linear material that exponentially stiffens when biaxially 228 
stretched [10]. As stiffness is defined as the resistance to bending or deformation, it is proposed that 229 
as skin exponentially stiffens with an increase in strain. This results in the force needed to deform the 230 
skin and insert the needles will increase significantly with biaxial stretching.  231 
Following microneedle insertion, the formed puncture sites were visualised by application of Gentian 232 
Violet Dye. The percentage of successful microneedle insertions is shown in Figure 5 for the two 233 
microneedle systems. It is evident that as the biaxial strain of the skin sample increases, an increase 234 
in the number of successful microneedle insertions was observed for the Dermapen®, which then 235 
plateaus as the skin was subjected to further biaxial strain. For the DermastampTM, as the biaxial strain 236 
of the skin increases, we observed a rise in the percentage of successful microneedle insertion. 237 
However, as biaxial strain of the skin was increased further, the percentage of successful microneedle 238 
insertion into the skin decreased.  239 
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Previous work by Maiti et al has shown that subjecting the skin to strain may help smooth its surface  240 
[21]. Such topographical change in skin structure may help mitigate the presence of micro-furrows on 241 
the skin which fold around the microneedles and can present resistance to microneedle insertion [22]. 242 
One of the ways to achieve skin smoothening is via subjecting the skin to strain or stretching [23]. 243 
However, the current work suggests that smoothening the skin by subjecting the skin to biaxial strain 244 
may help improve microneedle insertion up to an optimum strain (1.0625 and 1.125) as shown with 245 
the DermastampTM in Figure 5. Beyond this optimum strain, the percentage of successful microneedle 246 
penetration decreases due to increased skin stiffness with increasing strain as shown by previous 247 
investigators [10]. 248 
For the Dermapen®, the increase in the percentage of successful microneedle insertions with 249 
increasing strain is attributed to the observation that the skin smooths upon stretching [23]. 250 
Subjecting the skin to biaxial strain results in flattening of the micro-furrows and permits an increased 251 
probability of the needles puncturing through the stratum corneum. This is due to the linear motor, 252 
that oscillates the microneedle array, providing a secondary force to assist with insertion into the skin, 253 
irrespective of the rise in skin stiffness with the increasing strain. These results demonstrate that the 254 
Dermapen® is more effective than the DermastampTM in generating microneedle channels across the 255 
skin. 256 
Unlike the DermastampTM, the presence of plastic shoulders at the tip of microneedle cartridge of the 257 
Dermapen® imposes an additional surface tension to the skin during microneedle application. This 258 
helps to further mitigate the propensity of the skin to fold around the needles while mitigating the 259 
variability in puncture force. This is evidenced by the smaller standard deviation error bar for 260 
Dermapen® relative to DermastampTM for the level of skin strain investigated shown in Figure 4. The 261 
combination of these physical factors mimics the insertion mechanism of a mosquito’s proboscis. The 262 
shoulder of the cartridge of the Dermapen® plays a similar role to that of the mosquito labium which 263 
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applies lateral strain to the skin prior to puncture. This ultimately focusses the force at the tip of the 264 
Dermapen® permitting a more effective insertion [24].  The microneedles in this case are equivalent 265 
to the mosquito’s labrum which insert itself at defined frequency in a stamping manner allowing 266 
deeper insertion with repeated insertion. 267 
4.2. In vitro skin simulant insertion depth study of commercial microneedle 268 
An in-vitro skin simulant study, using Parafilm M®, was performed to compare the percentage of 269 
successful microneedle channels against depth for the two commercial microneedle systems being 270 
considered; the Dermapen® and DermastampTM. 271 
The insertion profiles of the commercial microneedle systems were established using a methodology 272 
developed and validated by Larraneta et al. [15]. It involves the insertion of the microneedle devices 273 
into a stack of eight Parafilm M® layers, followed by the separation of the layers and their visualisation 274 
under an optical microscope to evaluate the number of microneedle channels formed, leading to the 275 
insertion profiles in Figure 6. 276 
The two microneedle systems typically pierce the first five layers, with approximately 100% of the 277 
needles piercing the first three layers before the percentage of microchannels generated begins to 278 
decrease. The generated channels displayed uniform geometry as shown in Figure 6 (a) and (b). 279 
However, less than 50% of the microneedles successfully pierced the fifth and sixth layer.  280 
Hutton et al showed that microneedle patches fabricated from a copolymer of methyl vinyl ether and 281 
maleic acid were capable of penetrating the Parafilm M®  layers to a depth of approximately 60% of 282 
the microneedle height [25]. Vora et al also showed that microneedles fabricated from poly(vinyl 283 
pyrrolidone) (PVP) loaded with nano- and microparticles  were capable of penetrating the Parafilm 284 
layers up to 60% of the microneedle length [26]. This work aligns with our findings that the commercial 285 
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microneedle systems were capable of penetrating Parafilm M® layers up to circa 60% of the 286 
microneedle length. Furthermore, the results in Figure 6 (c) suggest that for an in vitro skin simulant 287 
model, the insertion profiles are similar for both microneedle systems. In a follow up study, Larraneta 288 
et al discovered that the insertion profile of microneedle arrays was more dependent on needle 289 
density and design rather than the material used [27]. Such observations may explain the similar 290 
insertion profiles of the two commercial microneedles systems, as both microneedles are made from 291 
the same material; stainless steel.   292 
4.3. Ex vivo skin insertion study 293 
An ex vivo penetration study was conducted to ascertain the microneedle penetration depth of the 294 
two different commercially available microneedle systems in actual skin tissue. Figure 7 shows that 295 
successful penetration of microneedles into ex vivo porcine flank skin evidenced from the visualisation 296 
of microneedle channels from cryo-sectioned skin samples. From Figure 7 it was apparent that the 297 
region surrounding the microneedle pore retained a normal structure with intact stratum corneum. 298 
However, the microneedle channels displayed a deep indentation with disrupted stratum corneum. 299 
In the context of drug delivery, it has been shown by Andrews et al that drug entry into and across the 300 
skin is not just limited by the outermost layer of the skin, the stratum corneum, but the penetration 301 
of molecules is limited by the overall epidermis itself [28]. This would suggest that both microneedle 302 
systems were capable of perforating the skin to generate microneedle channels which could be used 303 
by drug molecules to enter deeper layers of the skin.  304 
It was evident that the microneedle penetration depth by the Dermapen® was significantly deeper in 305 
comparison to the DermastampTM. Such observation may be attributed to the oscillating motion of the 306 
device during skin application which has been suggested to improve skin penetration [29]. Previous 307 
work by Izumi et al investigated the influence of vibration on the penetration of microneedles into an 308 
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in vitro silicone skin model. The group observed that the application of vibrating microneedles at 30 309 
Hz during skin application resulted in a reduction in the force needed to penetrate the skin [30]. This 310 
reduction in puncture force is attributed to the reduction in effective frictional forces experienced by 311 
microneedles under vibration [31].  The rapid vibration of the microneedles also mitigates the 312 
likelihood of viscoelastic materials such as skin from attaching to the microneedle during the insertion 313 
step. This reduction of effective frictional forces experienced by oscillating microneedles may also 314 
serve as an explanation as to why the Dermapen® displayed lower peak insertion force in comparison 315 
to the DermastampTM, shown in Figure 4.  316 
Another factor that may influence microneedle insertion into the skin is the different organization of 317 
the microneedles on the Dermastamp and Dermapen systems. From Figure 7 (a) and (b) along with 318 
microscopy image from Figure 6 (a) and (b) it is evident that the 36 microneedles on the Dermapen® 319 
are organised in rows whereas the 42 microneedles on the DermastampTM are organised in concentric 320 
circles. The needles on Dermapen® are closely distributed to one another in comparison to the needles 321 
on the DermastampTM. Previous work by Olatunji et al highlighted that insertion force increases with 322 
when microneedle interspacing decreases [32]. In contrast to the finding by Olatunji et al, we observed 323 
that although the needle interspacing on the Dermapen® are closer than the DermastampTM, the 324 
Dermapen® still required less insertion than the DermastampTM. By comparing our findings to that of 325 
Olatunji et al, it can be postulated that the method (oscillating vs non-oscillating) in which the 326 
microneedle is applied to the skin overrides the influence of microneedle interspacing on insertion 327 
force and penetration depth.  328 
By comparing the penetration data for both microneedle systems from Figure 6 and Figure 7, it is 329 
evident that the insertion of microneedles into in vitro skin simulant, Parafilm M® stacks, were 330 
significantly deeper than that of ex vivo skin tissue. Such disparity in results suggest that the in vitro 331 
test developed by Larraneta et al may have some limitations when the insertion data is translated to 332 
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ex vivo tissues and potentially in vivo. Both Parafilm M® and skin are inherently viscoelastic materials 333 
which display both elastic and viscous properties under deformation. Unlike skin, which is an elastic 334 
biological tissue that  returns to its normal state after mild stretching or compression [33], Parafilm 335 
M® exhibits irreversible plastic deformation when stretched or compressed [34].  336 
4.4. Skin permeation study  337 
A permeation study was conducted to investigate the effect of different commercial microneedle 338 
systems on the permeation of a model drug, imiquimod that displayed poor cutaneous permeation 339 
[2]. One of the strategies to overcome the limited permeation of imiquimod is to employ permeation 340 
enhancing strategy such as microneedle. Upon microneedle application, transient microchannels are 341 
generated within the skin that promote the delivery of the drug across the skin. The amount of 342 
imiquimod (µg) recovered from the various Franz cell components following the 24-hour permeation 343 
study is displayed in Figure 8.  344 
For all treatment modalities, we observed no statistical difference in the amount of imiquimod 345 
recovered from different Franz cell components (donor wash, skin wash, tape strips and remaining 346 
skin) except for the receptor fluid. With regards to receptor fluid, it was seen that when the skin was 347 
pre-treated with either microneedle systems, we observed enhanced delivery of imiquimod across 348 
the skin relative to the cream only control.  However, it was worth noting we observed no statistical 349 
difference in the permeation of imiquimod into the receptor fluid between Dermapen® and 350 
DermastampTM.  351 
One possibility for the similarity permeation profile for the two microneedle systems is attributed the 352 
fact that both systems successfully breached the stratum corneum, epidermis and down to superficial 353 
dermis as highlighted in Figure 7 (c) and (d). It has been reported that thickness porcine epidermal 354 
layer varies between 30-140 µm [35] and it was shown that both microneedle system penetrated into 355 
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the porcine skin to a depth of at least 200 µm, reaching the dermal layer of the skin. This layer of the 356 
skin is viscoelastic due to the presence of a dense network of collagen and elastin [36–38]. Although 357 
the Dermapen® may puncture the skin deeper than the DermastampTM, immediately upon 358 
microneedle removal the channels generated in the dermal layer of the skin immediately recoils and 359 
reseals conferring similar resistance in permeation for imiquimod across the dermis for both 360 
microneedle systems. A limitation which is frequently highlighted when a patch-and-poke strategy is 361 
adopted for solid microneedles systems [39]. 362 
5.0 Conclusion 363 
In conclusion, this work expands our knowledge on the mechanical insertion of microneedles into the 364 
skin. Applying biaxial strain on the skin indeed influences the penetration of microneedles into the 365 
skin. It was apparent that the two commercially available microneedle systems, Dermapen® and 366 
DermastampTM have very different insertion force profiles with increasing strain. For all the skin strain 367 
levels investigated, it was evident that the Dermapen® required less insertion force than the 368 
DermastampTM. Interestingly, the percentage of successful insertion continues to increase before 369 
plateauing with increasing skin strain for the oscillating Dermapen®. In contrast for the Dermastamp™, 370 
the percentage of successful microneedle insertions increases with strain before decreasing at higher 371 
strain rate. In terms of insertion depth, it was apparent that the penetration of the Dermapen® was 372 
much deeper than that of the DermastampTM. Such a difference was not detected when the 373 
microneedle systems were evaluated using the commonly used Parafilm M® stack insertion study but 374 
only became apparent when the devices were evaluated ex vivo. The lower insertion force and deeper 375 
penetration provided by the Dermapen® was attributed to the oscillating feature of the microneedle 376 
system which mitigates the effective frictional force experienced by the needle during skin insertion. 377 
Lastly, although the Dermapen® may puncture the skin deeper than the DermastampTM, such 378 
difference in penetration did not affect the permeation profile of the model drug, imiquimod across 379 
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Figures and legends 513 
 514 











Figure 3 - Schematic detailing the setup to investigate effect of biaxial strain on microneedle skin 522 
insertion. A 40x40 mm grid of 5 mm squares ink was stamped onto the skin samples in Step (a) in 523 
order to measure the level of biaxial strain on the skin. Using a texture analyser (TA), respective 524 
microneedle systems were attached to the probe of the instrument to allow insertion into the skin as 525 
shown in Step (b). Visualisation of microneedle channels using Gentian Violet dye as depicted in  526 







Figure 4 Biaxial skin strain and insertion force relationship for commercial microneedle systems 532 
Dermapen® and DermastampTM. Data expressed as means ± SD, n=5. 533 
 534 
Figure 5 Averaged percentage of maximum number of dyed microneedle insertion holes generated 535 
for each level of stretch. Data expressed as means ± SD, n=5 536 
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Figure 6 Microscopic images of first layer of Parafilm M® stack punctured by stainless steel 538 
microneedles by (a) Dermapen®, (b) DermastampTM Scale bar:300 µm (c)Insertion profile of different 539 
commercial microneedle systems, Dermapen® and DermastampTM into Parafilm M® layers, data 540 




Figure 7 Visual image of porcine flank skin surface after gentian staining following (a) Dermapen® and 543 
(b) DermastampTM application. Optical microscopy images of porcine flank skin cross sections after 544 
application of (c) Dermapen and (d) Dermastamp. The skin was stained with 1% gentian violet solution 545 
to allow visualisation of microneedle channels formed after microneedle treatment. n=10, data is 546 




Figure 8 HPLC analysis of the mean amount of imiquimod recovered from the different Franz cell 549 
components (donor chamber wash, skin wash, tape strips, remaining skin and receptor fluid) post-550 
permeation study. Data is presented as the mean ± SEM (n = 6). Differences were calculated using 551 
one-way ANOVA, followed by Tukey’s post hoc test, and deemed significant at p<0.05. n.s = not 552 
statistically significant at p>0.05 553 
